期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
From COVID-19 to Nipah virus preparedness in low-and middle-income countries:Re-centering points of decision and responsible AI 认领 引用 被引量:1
1
作者 Giao Huynh Han Thi Ngoc Nguyen +3 位作者 Ly Trieu Vo Emily Evans Nhut Minh Vuong Pham Le An 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2026年第4期145-147,共3页
Nipah virus(NiV)is a zoonotic pathogen that causes severe neurological and respiratory diseases characterized by high mortality rates[1].The emergence of sporadic cases in Bangladesh in 2025 and subsequent infections ... Nipah virus(NiV)is a zoonotic pathogen that causes severe neurological and respiratory diseases characterized by high mortality rates[1].The emergence of sporadic cases in Bangladesh in 2025 and subsequent infections among healthcare workers in West Bengal in early 2026 highlight a significant epidemic potential[2].This risk is further exacerbated by the absence of licensed vaccines or targeted antiviral therapies[1,3,4].Consequently,there is an urgent need for strengthened surveillance and operational preparedness in low-and middle-income countries(LMICs),which often face resource-limited healthcare systems and overcrowded settings with inadequate infection prevention and control(IPC)measures[1,5]. 展开更多
关键词 targeted antiviral therapies consequentlythere zoonotic pathogen severe neurological respiratory diseases preparedness nipah virus covid nipah virus niv low middle income countries
暂未订购 下载PDF
Utility of the China-PAR Score in predicting secondary events among patients undergoing percutaneous coronary intervention 认领 引用
2
作者 Jianxin Li Xueyan Zhao +10 位作者 Jingjing Xu Pei Zhu Ying Song Yan Chen Lin Jiang Lijian Gao Lei Song Yuejin Yang Runlin Gao Xiangfeng Lu Jinqing Yuan 《Chinese Medical Journal》 SCIE CAS CSCD 2025年第5期598-600,共3页
To the Editor:Coronary artery disease(CAD)is the leading cause of mortality worldwide.Effective treatments,such as percutaneous coronary intervention(PCI),have reduced the mortality of patients with CAD and have trans... To the Editor:Coronary artery disease(CAD)is the leading cause of mortality worldwide.Effective treatments,such as percutaneous coronary intervention(PCI),have reduced the mortality of patients with CAD and have transitioned most of them to the chronic phase of cardiovascular disease(CVD).Consequently,there is a high demand for secondary prevention strategies to reduce adverse outcomes of CAD.Risk assessment can quantify the residual risk,identify patients at high secondary risk,and facilitate informed preventive treatment decisions.[1]However,the existing scoring systems for secondary risk,such as the Global Registry of Acute Coronary Events(GRACE)and Patterns of Non-Adherence to Anti-Platelet Regimen in Stented Patients(PARIS)scores,usually involve certain clinical indicators that are unfamiliar to the public and demonstrate poor performance when applied to Chinese patients;Thus,it limited their utility,especially as self-assessment tools.The Prediction for Atherosclerotic Cardiovascular Disease Risk in China(China-PAR)score is a guideline-recommended pragmatic tool for primary prevention using several conventional risk factors.[2]The risk factors related to primary CVD are likely implicated in the recurrent events because of the same underlying pathophysiology of atherosclerosis. 展开更多
关键词 informed preven coronary artery disease risk assessment percutaneous coronary intervention pci percutaneous coronary intervention secondary prevention secondary prevention strategies cardiovascular disease cvd consequentlythere
上一页 1 下一页 到第
在线咨询 使用帮助 返回顶部 意见反馈